168 related articles for article (PubMed ID: 36809998)
21. Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine.
Fiume L; Bolondi L; Busi C; Chieco P; Kratz F; Lanza M; Mattioli A; Di Stefano G
J Hepatol; 2005 Oct; 43(4):645-52. PubMed ID: 16023760
[TBL] [Abstract][Full Text] [Related]
22. Piperlongumine inhibits diethylnitrosamine induced hepatocellular carcinoma in rats.
Kumar A; Naithani M; Kumar N; Singh N; Agrawal S; Sharma A; Thapliyal S; Singh J; Handu S
Hum Exp Toxicol; 2022; 41():9603271211073593. PubMed ID: 35113675
[TBL] [Abstract][Full Text] [Related]
23. A novel interaction of nucleophosmin with BCL2-associated X protein regulating death evasion and drug sensitivity in human hepatoma cells.
Lo SJ; Fan LC; Tsai YF; Lin KY; Huang HL; Wang TH; Liu H; Chen TC; Huang SF; Chang CJ; Lin YJ; Yung BY; Hsieh SY
Hepatology; 2013 May; 57(5):1893-905. PubMed ID: 23258611
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic effect of carnosine in rat model of experimental liver carcinogenesis.
Fouad AA; Qutub HO; Al Rashed AS; Al-Melhim WN
Environ Toxicol Pharmacol; 2017 Dec; 56():10-14. PubMed ID: 28863318
[TBL] [Abstract][Full Text] [Related]
25. Hepatoprotective, antioxidant and anti-inflammatory potentials of Vit-E/C@SeNPs in rats: Synthesis, characterization, biochemical, radio-biodistribution, molecular and histopathological studies.
Aljuhr SA; Abdelaziz G; Essa BM; Zaghary WA; Sakr TM
Bioorg Chem; 2021 Dec; 117():105412. PubMed ID: 34649153
[TBL] [Abstract][Full Text] [Related]
26. Selective ablation of Notch3 in HCC enhances doxorubicin's death promoting effect by a p53 dependent mechanism.
Giovannini C; Gramantieri L; Chieco P; Minguzzi M; Lago F; Pianetti S; Ramazzotti E; Marcu KB; Bolondi L
J Hepatol; 2009 May; 50(5):969-79. PubMed ID: 19304334
[TBL] [Abstract][Full Text] [Related]
27. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma.
Li H; Liu Y; Jiang W; Xue J; Cheng Y; Wang J; Yang R; Zhang X
BMC Cancer; 2021 Mar; 21(1):318. PubMed ID: 33765973
[TBL] [Abstract][Full Text] [Related]
28. The Protective Role of Etoricoxib Against Diethylnitrosamine/2-acetylaminofluorene- Induced Hepatocarcinogenesis in Wistar Rats: The Impact of NF-κB/COX-2/PGE2 Signaling.
Ali G; Omar H; Hersi F; Abo-Youssef A; Ahmed O; Mohamed W
Curr Mol Pharmacol; 2022; 15(1):252-262. PubMed ID: 34238176
[TBL] [Abstract][Full Text] [Related]
29. A novel chemoprotective effect of tiopronin against diethylnitrosamine-induced hepatocellular carcinoma in rats: Role of ASK1/P38 MAPK-P53 signalling cascade.
Mo'men YS; Hussein RM; Kandeil MA
Clin Exp Pharmacol Physiol; 2020 Feb; 47(2):322-332. PubMed ID: 31663622
[TBL] [Abstract][Full Text] [Related]
30. Anticancer Effects of Tacrolimus on Induced Hepatocellular Carcinoma in Mice.
Mahmoud SS; Hussein S; Rashed H; Abdelghany EMA; Ali AI
Curr Mol Pharmacol; 2022; 15(2):434-445. PubMed ID: 34061012
[TBL] [Abstract][Full Text] [Related]
31. Synergistic effect of nutlin-3 combined with aspirin in hepatocellular carcinoma HepG2 cells through activation of Bcl-2/Bax signaling pathway.
Miao R; Xu X; Wang Z; Liu S; Qu K; Chen W; Liu C
Mol Med Rep; 2018 Mar; 17(3):3735-3743. PubMed ID: 29286113
[TBL] [Abstract][Full Text] [Related]
32. Phenolics-Enriched Fraction of
Pal LC; Prateeksha ; Singh BN; Pande V; Rao CV
Nutr Cancer; 2022; 74(3):1106-1121. PubMed ID: 34018459
[TBL] [Abstract][Full Text] [Related]
33.
Moawed FS; Haroun RA; Abou Zaid ES; Mansour SZ; Badawi AM; Kandil EI
Int J Immunopathol Pharmacol; 2023; 37():3946320231180708. PubMed ID: 37276131
[No Abstract] [Full Text] [Related]
34. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
[TBL] [Abstract][Full Text] [Related]
35. Aidi injection enhances the anti-tumor impact of doxorubicin in H22 tumor-containing mice.
Lu Y; Zhang S; Zhu X; Wang K; He Y; Liu C; Sun J; Pan J; Zheng L; Liu W; Li Y; Huang Y; Liu T
J Ethnopharmacol; 2023 Mar; 303():115968. PubMed ID: 36473617
[TBL] [Abstract][Full Text] [Related]
36. Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model.
Abdel-Hamid NI; El-Azab MF; Moustafa YM
Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):379-395. PubMed ID: 28070612
[TBL] [Abstract][Full Text] [Related]
37. Vitamin K analog (compound 5) induces apoptosis in human hepatocellular carcinoma independent of the caspase pathway.
Enokimura N; Shiraki K; Kawakita T; Saitou Y; Inoue H; Okano H; Yamamoto N; Sugimoto K; Carr BI; Nakano T
Anticancer Drugs; 2005 Sep; 16(8):837-44. PubMed ID: 16096431
[TBL] [Abstract][Full Text] [Related]
38. WP1130 increases doxorubicin sensitivity in hepatocellular carcinoma cells through usp9x-dependent p53 degradation.
Liu H; Chen W; Liang C; Chen BW; Zhi X; Zhang S; Zheng X; Bai X; Liang T
Cancer Lett; 2015 Jun; 361(2):218-25. PubMed ID: 25749422
[TBL] [Abstract][Full Text] [Related]
39. Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.
Wang C; Gao D; Guo K; Kang X; Jiang K; Sun C; Li Y; Sun L; Shu H; Jin G; Sun H; Wu W; Liu Y
BMC Cancer; 2012 May; 12():166. PubMed ID: 22559167
[TBL] [Abstract][Full Text] [Related]
40. Aspirin enhances the sensitivity of hepatocellular carcinoma side population cells to doxorubicin via miR-491/ABCG2.
Xie ZY; Liu MS; Zhang C; Cai PC; Xiao ZH; Wang FF
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30120100
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
